Amyloid β structural polymorphism, associated toxicity and therapeutic strategies

Area of Science:

• Neuroscience
• Biochemistry
• Pharmacology

Background:

• Amyloid-beta (Aβ) oligomers exhibit significant structural and functional diversity.
• The assembly pathways and conformational stability of Aβ species are influenced by environmental factors and molecular interactions.
• A comprehensive understanding of Aβ oligomer toxicity in neurodegeneration remains incomplete.

Purpose of the Study:

• To review the principles of Aβ oligomer involvement in neurodegeneration.
• To provide an overview of inhibitors and inducers of Aβ oligomerization as potential therapeutics.
• To discuss Aβ assembly mechanisms, structural polymorphism, and interactions.

Main Methods:

• Literature review of multidisciplinary scientific studies.
• Analysis of in vitro and preclinical data on Aβ neurotoxicity.
• Examination of Aβ aggregation pathways and interactions with other molecules.

Main Results:

• Aβ oligomeric species vary in molecular weight, conformation, and morphology.
• Different Aβ species display distinct stability, function, and neurotoxicity profiles.
• Interactions with lipids and proteins, along with environmental factors, modulate Aβ aggregation.

Conclusions:

• Targeting specific Aβ oligomeric species and their assembly pathways offers therapeutic potential for neurodegenerative diseases.
• Developing effective inhibitors or inducers requires a deeper understanding of Aβ structural polymorphism and toxicity.
• Further research into Aβ-molecule interactions is crucial for advancing therapeutic strategies.